You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY20 is not expected to be complete until September, 2021.

  1. Signal Processing/Automation for Cardiac Output Monitor

    SBC: Axon Medical Inc            Topic: N/A

    Thermal dilution is by far the most common method of measuring cardiac output. Over onemillion thermodilution pulmonary artery catheters are used each year in the U.S. We have appliedartificial neural networks to improve the accuracy of the thermal dilution cardiac output measurementand allow using small injectate volumes (2 ml). We will build an automated system using a modifiedsyringe pump and a ...

    SBIR Phase I 1994 Department of Health and Human Services
  2. Intravaginal Lactobacillus Suppository for Prophylaxis

    SBC: Chrisope Technologies, Inc.            Topic: N/A

    The long-term goal of this project is to develop a commercially available vaginal suppositorycontaining a H2O2-producing strain of Lactobacillus for use in colonization of the vagina. Vaginallactobacilli are the primary microbial defense against infection. Lactobacillus predominant vaginal florais associated with decreased frequencies of gonorrhea and chlamydia infections. Women withH2O2-producing ...

    SBIR Phase I 1994 Department of Health and Human Services
  3. Preparation of Vaginal Lactobacillus Suppository

    SBC: Chrisope Technologies, Inc.            Topic: N/A

    N/A

    SBIR Phase I 1994 Department of Health and Human Services
  4. Stand Alone Uterine Manipulator

    SBC: Clinical Innovations, Inc.            Topic: N/A

    N/A

    SBIR Phase I 1994 Department of Health and Human Services
  5. Pediatric Computerized Severity Index

    SBC: Int'l Severity Information            Topic: N/A

    N/A

    SBIR Phase I 1994 Department of Health and Human Services
  6. Development of GD DTPA Bisglucosamide for MRI Contrast

    SBC: Magnetic Research, Inc.            Topic: N/A

    N/A

    SBIR Phase I 1994 Department of Health and Human Services
  7. Quantitative Assessment of Microembolic Involvement

    SBC: MEDICAL PHYSICS, INC.            Topic: N/A

    We will establish the feasibility for applying a new and noninvasive method to the developmentof a practical instrument for sensitive and quantitative detection of microembolic involvement in humanlungs. Because present methods for detection of pulmonary emboli utilize imaging techniques, the sizeof emboli detectable by these methods are limited by the inherent spacial resolution of x-ray and gamm ...

    SBIR Phase I 1994 Department of Health and Human Services
  8. AN OPERATING ENVIRONMENT FOR SCIENTIFIC COMPUTING

    SBC: Micromath Inc.            Topic: N/A

    INITIAL DESIGN AND TESTING OF THE MICROMATH SCIENTIFIC COMPUTING ENVIRONMENT (MMSCE) WILL BE CARRIED OUT. THE MMSCE EMBODIES AN OBJECT ORIENTED APPROACH TO SCIENTIFIC COMPUTING. "COMPUTATIONAL NODES" ARE DEFINED HERE AS ENTITIES BETWEEN WHICH DATA AND OTHER MESSAGES FLOW. IN THE MMSCE, THE SCENTIST-USER MANIPULATES COMPUTATIONAL NODES, AUTOMCATICALLY LINKING POTENTIALLY DIVERSE TYPES OF SCIENTIFIC ...

    SBIR Phase II 1994 Department of Health and Human Services
  9. Externally Powered Hand Orthosis--High Mobility Wrist

    SBC: MOTION CONTROL, INC            Topic: N/A

    Our purpose is to develop orthotic devices that will improve hand function for people withparalyzed upper limbs. Existing devices that allow for some hand function for people with paralyzedupper limbs are based on the World Health Organization 1954 tenodesis orthotic splint. Developmentsover the past decade have provided the possibility for devising orthoses that can be controlled by signalsfrom s ...

    SBIR Phase I 1994 Department of Health and Human Services
  10. NMDA Receptor Antagonists That Spare LTP

    SBC: NPS Pharmaceuticals, Inc.            Topic: N/A

    The N-methyl-D-aspartate (NMDA) subtype of glutamate receptor has been implicated in avariety of neurological pathologies including ischemic brain damage (stroke), head trauma, spinal cordinjury, epilepsy, neurodegenerative disorders such as Alzheimer's Disease, and hyperalgesic states. Thedevelopment of NMDA antagonists as therapeutants, however, has been hampered by the occurrenceof deleterious ...

    SBIR Phase I 1994 Department of Health and Human Services
US Flag An Official Website of the United States Government